These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 15252744
21. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Durand E, Mousseaux E, Coste P, Pillière R, Dubourg O, Trinquart L, Chatellier G, Hagège A, Desnos M, Lafont A. Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702 [Abstract] [Full Text] [Related]
22. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy]. Chernov SA, Kucherov VV, Fursov AN, Zakharova EG, Gaĭdukov AV, Liapkova NB, Korneev NV, Pestovskaia OR. Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021 [No Abstract] [Full Text] [Related]
23. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer zu Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, Kuhn H. J Am Coll Cardiol; 2007 Jun 19; 49(24):2356-63. PubMed ID: 17572252 [Abstract] [Full Text] [Related]
24. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C. Clin Res Cardiol; 2008 Apr 19; 97(4):234-43. PubMed ID: 18071624 [Abstract] [Full Text] [Related]
25. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. Alam M, Dokainish H, Lakkis N. J Interv Cardiol; 2006 Aug 19; 19(4):319-27. PubMed ID: 16881978 [Abstract] [Full Text] [Related]
26. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures. Dörge H, Schmitto JD, Liakopoulos OJ, Walther S, Schöndube FA. Thorac Cardiovasc Surg; 2004 Dec 19; 52(6):344-8. PubMed ID: 15573275 [Abstract] [Full Text] [Related]
27. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy. Jiang TY, Wu XS, Lu Q, Meng X, Jia CQ, Zhang Y. Chin Med J (Engl); 2004 Feb 19; 117(2):296-8. PubMed ID: 14975219 [No Abstract] [Full Text] [Related]
28. Substitution of ethanol with specially designed microspheres in a TASH procedure. Latsios G, Gerckens U, Mueller R, Grube E. EuroIntervention; 2011 Feb 19; 6(7):889-92. PubMed ID: 21252025 [Abstract] [Full Text] [Related]
29. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Götte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC. Circulation; 2005 May 17; 111(19):2503-8. PubMed ID: 15867172 [Abstract] [Full Text] [Related]
30. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach. Aksu T, Guler T, Yalin K, Golcuk SE, Ozcan K. Am J Med Sci; 2016 Nov 17; 352(5):466-471. PubMed ID: 27865293 [Abstract] [Full Text] [Related]
31. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing]. Krejcí J, Groch L, Meluzín J, Vykypel T, Halámek J, Vitovec J. Vnitr Lek; 2006 Apr 17; 52(4):313-20. PubMed ID: 16755987 [Abstract] [Full Text] [Related]
32. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR. Circulation; 2008 Jul 08; 118(2):131-9. PubMed ID: 18591440 [Abstract] [Full Text] [Related]
33. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. Nagueh SF, Buergler JM, Quinones MA, Spencer WH, Lawrie GM. J Am Coll Cardiol; 2007 Aug 21; 50(8):795-8. PubMed ID: 17707185 [Abstract] [Full Text] [Related]
34. Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation. Vural AH, Tiryakioğlu O, Türk T, Ata Y, Ari H, Yalçinkaya S, Erkut B, Bozat T, Ozyazicioğlu A. Heart Surg Forum; 2007 Aug 21; 10(6):493-7. PubMed ID: 18187386 [Abstract] [Full Text] [Related]
35. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR. J Am Coll Cardiol; 2004 Dec 21; 44(12):2329-32. PubMed ID: 15607394 [Abstract] [Full Text] [Related]
36. Endocardial septal ablation for hypertrophic obstructive cardiomyopathy. Aksu T, Güler TE, Yalın K, Gölcük ŞE, Özcan KS. Turk Kardiyol Dern Ars; 2017 Jan 21; 45(1):67-72. PubMed ID: 28106021 [Abstract] [Full Text] [Related]
37. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Simon RD, Crawford FA, Spencer WH, Gold MR. Pacing Clin Electrophysiol; 2005 Dec 21; 28(12):1354-6. PubMed ID: 16403169 [Abstract] [Full Text] [Related]
38. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. van der Lee C, ten Cate FJ, Geleijnse ML, Kofflard MJ, Pedone C, van Herwerden LA, Biagini E, Vletter WB, Serruys PW. Circulation; 2005 Jul 26; 112(4):482-8. PubMed ID: 16027255 [Abstract] [Full Text] [Related]
39. Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography. Sommer A, Poulsen SH, Mogensen J, Thuesen L, Egeblad H. Eur J Echocardiogr; 2010 Dec 26; 11(10):883-8. PubMed ID: 20667848 [Abstract] [Full Text] [Related]
40. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy. Crossen K, Jones M, Erikson C. Heart Rhythm; 2016 Sep 26; 13(9):1885-90. PubMed ID: 27132152 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]